<![CDATA[SKY-0515 Demonstrates Sustained Mutant Huntingtin Lowering in Latest Phase 1/2 Study Update]]>
Post Content: Source: Neurology Read More
<![CDATA[Factors Associated With Response to Cognitive Rehabilitation in Progressive MS: Cecilia Meza, MA]]>
Post Content: Source: Neurology Read More
<![CDATA[New Clinical Data Reinforce Opakalim’s Potential as a Selective Antiseizure Therapy Option]]>
Post Content: Source: Neurology Read More
<![CDATA[Real-World Registry Data Support Eculizumab, Ravulizumab as Effective Treatments for NMOSD]]>
Editors’ Picks, May 2026: Insights Into CAR T Therapy, Neuron-Tumor Crosstalk in Pancreatic Cancer, and More
What APA Is Doing for You: Update on Clozapine REMS
In November 2021, the Food and Drug Administration (FDA) instituted a new Clozapine Risk Evaluation and Mitigation Strategy (REMS) to…
Read More
